SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis
- PMID: 33521734
- PMCID: PMC7837230
- DOI: 10.1016/S2666-5247(20)30172-5
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis
Abstract
Background: Viral load kinetics and duration of viral shedding are important determinants for disease transmission. We aimed to characterise viral load dynamics, duration of viral RNA shedding, and viable virus shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in various body fluids, and to compare SARS-CoV-2, SARS-CoV, and Middle East respiratory syndrome coronavirus (MERS-CoV) viral dynamics.
Methods: In this systematic review and meta-analysis, we searched databases, including MEDLINE, Embase, Europe PubMed Central, medRxiv, and bioRxiv, and the grey literature, for research articles published between Jan 1, 2003, and June 6, 2020. We included case series (with five or more participants), cohort studies, and randomised controlled trials that reported SARS-CoV-2, SARS-CoV, or MERS-CoV infection, and reported viral load kinetics, duration of viral shedding, or viable virus. Two authors independently extracted data from published studies, or contacted authors to request data, and assessed study quality and risk of bias using the Joanna Briggs Institute Critical Appraisal Checklist tools. We calculated the mean duration of viral shedding and 95% CIs for every study included and applied the random-effects model to estimate a pooled effect size. We used a weighted meta-regression with an unrestricted maximum likelihood model to assess the effect of potential moderators on the pooled effect size. This study is registered with PROSPERO, CRD42020181914.
Findings: 79 studies (5340 individuals) on SARS-CoV-2, eight studies (1858 individuals) on SARS-CoV, and 11 studies (799 individuals) on MERS-CoV were included. Mean duration of SARS-CoV-2 RNA shedding was 17·0 days (95% CI 15·5-18·6; 43 studies, 3229 individuals) in upper respiratory tract, 14·6 days (9·3-20·0; seven studies, 260 individuals) in lower respiratory tract, 17·2 days (14·4-20·1; 13 studies, 586 individuals) in stool, and 16·6 days (3·6-29·7; two studies, 108 individuals) in serum samples. Maximum shedding duration was 83 days in the upper respiratory tract, 59 days in the lower respiratory tract, 126 days in stools, and 60 days in serum. Pooled mean SARS-CoV-2 shedding duration was positively associated with age (slope 0·304 [95% CI 0·115-0·493]; p=0·0016). No study detected live virus beyond day 9 of illness, despite persistently high viral loads, which were inferred from cycle threshold values. SARS-CoV-2 viral load in the upper respiratory tract appeared to peak in the first week of illness, whereas that of SARS-CoV peaked at days 10-14 and that of MERS-CoV peaked at days 7-10.
Interpretation: Although SARS-CoV-2 RNA shedding in respiratory and stool samples can be prolonged, duration of viable virus is relatively short-lived. SARS-CoV-2 titres in the upper respiratory tract peak in the first week of illness. Early case finding and isolation, and public education on the spectrum of illness and period of infectiousness are key to the effective containment of SARS-CoV-2.
Funding: None.
© 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.
Figures
Comment in
-
Rapid tests for quantification of infectiousness are urgently required in patients with COVID-19.Lancet Microbe. 2021 Jul;2(7):e286-e287. doi: 10.1016/S2666-5247(21)00089-6. Epub 2021 May 12. Lancet Microbe. 2021. PMID: 34002171 Free PMC article. No abstract available.
Similar articles
-
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.Lancet Psychiatry. 2020 Jul;7(7):611-627. doi: 10.1016/S2215-0366(20)30203-0. Epub 2020 May 18. Lancet Psychiatry. 2020. PMID: 32437679 Free PMC article.
-
Duration of viable virus shedding and polymerase chain reaction positivity of the SARS-CoV-2 Omicron variant in the upper respiratory tract: a systematic review and meta-analysis.Int J Infect Dis. 2023 Apr;129:228-235. doi: 10.1016/j.ijid.2023.02.011. Epub 2023 Feb 18. Int J Infect Dis. 2023. PMID: 36804640 Free PMC article.
-
Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.Elife. 2021 Apr 16;10:e65774. doi: 10.7554/eLife.65774. Elife. 2021. PMID: 33861198 Free PMC article.
-
Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature.Infect Control Hosp Epidemiol. 2021 Jun;42(6):659-668. doi: 10.1017/ice.2020.1273. Epub 2020 Oct 20. Infect Control Hosp Epidemiol. 2021. PMID: 33077007 Free PMC article. Review.
-
Gastrointestinal viral shedding in children with SARS-CoV-2: a systematic review and meta-analysis.World J Pediatr. 2022 Sep;18(9):582-588. doi: 10.1007/s12519-022-00553-1. Epub 2022 Jun 4. World J Pediatr. 2022. PMID: 35665477 Free PMC article. Review.
Cited by
-
COVID-19-related Pneumonitis in Immunocompromised Patients: Reviewing Clinical Features and Management Approaches.J Community Hosp Intern Med Perspect. 2024 Sep 9;14(5):63-72. doi: 10.55729/2000-9666.1399. eCollection 2024. J Community Hosp Intern Med Perspect. 2024. PMID: 39399191 Free PMC article. Review.
-
Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis.Eur J Med Res. 2024 Oct 4;29(1):484. doi: 10.1186/s40001-024-02062-5. Eur J Med Res. 2024. PMID: 39367485 Free PMC article.
-
SARS-CoV-2 Variants from Long-Term, Persistently Infected Immunocompromised Patients Have Altered Syncytia Formation, Temperature-Dependent Replication, and Serum Neutralizing Antibody Escape.Viruses. 2024 Sep 9;16(9):1436. doi: 10.3390/v16091436. Viruses. 2024. PMID: 39339912 Free PMC article.
-
Interactions of SARS-CoV-2 with Human Target Cells-A Metabolic View.Int J Mol Sci. 2024 Sep 16;25(18):9977. doi: 10.3390/ijms25189977. Int J Mol Sci. 2024. PMID: 39337465 Free PMC article. Review.
-
Personal characteristics and transmission dynamics associated with SARS-CoV-2 semi-quantitative PCR test results: an observational study from Belgium, 2021-2022.Front Public Health. 2024 Sep 10;12:1429021. doi: 10.3389/fpubh.2024.1429021. eCollection 2024. Front Public Health. 2024. PMID: 39319296 Free PMC article.
References
-
- Wölfel R, Corman VM, Guggemos W. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465–469. - PubMed
-
- The Joanna Briggs Institute The Joanna Briggs Institute Critical Appraisal tools for use in JBI systematic reviews. Checklist for case series. 2017. https://joannabriggs.org/sites/default/files/2019-05/JBI_Critical_Apprai...
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous